ORMP
NASDAQ · Pharmaceuticals
Oramed Pharmaceuticals Inc
$4.11
-0.12 (-2.84%)
Open$4.22
Previous Close$4.23
Day High$4.29
Day Low$4.08
52W High$5.47
52W Low$2.09
Volume—
Avg Volume108.4K
Market Cap161.81M
P/E Ratio0.93
EPS$4.13
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+132.4% upside
Current
$4.11
$4.11
Target
$9.55
$9.55
$5.95
$9.55 avg
$10.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.30M | 2.02M | 32.28M |
| Net Income | 59.45M | 58.29M | 5.51M |
| Profit Margin | 412.3% | 3,042.4% | 17.1% |
| EBITDA | -13,889,995 | -14,282,160 | 8.62M |
| Free Cash Flow | — | — | 3.23M |
| Rev Growth | — | -9.5% | +15.3% |
| Debt/Equity | — | — | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |